Get started
Author

Minghua Ge

Exploration of nanozymes in viral diagnosis and therapy
2022 · Jiyoung Lee, Hongwei Liao, et al. · Exploration · 173
PDF
CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment
2022 · Zongfu Pan, Tong Xu, et al. · Molecular Cancer · 134
PDF
Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial
2021 · Dapeng Li, Yihebali Chi, et al. · Clinical Cancer Research · 123
Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy
2023 · Yujia Liu, Jiafeng Wang, et al. · Drug Resistance Updates · 105
Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial
2022 · Dan Liu, Jun Zhou, et al. · BMC Medicine · 88
PDF
Expert consensus workshop report: Guidelines for thermal ablation of thyroid tumors (2019 edition)
2020 · Dong Xu, Minghua Ge, et al. · Journal of Cancer Research and Therapeutics · 74
First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety results of the randomised, phase III CHANGE-2 trial
2021 · Ye Guo, Yi Luo, et al. · European Journal of Cancer · 60
PDF
The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy
2023 · Yingying Gong, Lisha Bao, et al. · Molecular Cancer · 53
PDF
Integrative proteogenomic characterization reveals therapeutic targets in poorly differentiated and anaplastic thyroid cancers
2025 · Zongfu Pan, Zhuo Tan, et al. · Nature Communications · 52
PDF
Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial
2023 · Yihebali Chi, Xiangqian Zheng, et al. · Clinical Cancer Research · 47
PDF
Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission
2024 · Ya-wen Guo, Lei Zhu, et al. · Cell Death and Disease · 46
PDF
HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1
2020 · Zongfu Pan, Qilu Fang, et al. · Cancer Letters · 42
Prosapogenin A induces GSDME-dependent pyroptosis of anaplastic thyroid cancer through vacuolar ATPase activation-mediated lysosomal over-acidification
2024 · Yunye Liu, Yawen Guo, et al. · Cell Death and Disease · 38
Mirabegron displays anticancer effects by globally browning adipose tissues
2023 · Xiaoting Sun, Wenhai Sui, et al. · Nature Communications · 38
PDF
Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment
2021 · Lisha Bao, Tong Xu, et al. · Frontiers in Oncology · 38
PDF
Targeting one‐carbon metabolism for cancer immunotherapy
2024 · Xinxin Ren, Xiang Wang, et al. · Clinical and Translational Medicine · 37
PDF
ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma
2023 · Tong Xu, Chaozhuang Zhu, et al. · Journal of Experimental & Clinical Cancer Research · 36
PDF
The association between markers of liver injury and clinical outcomes in patients with COVID‐19 in Wuhan
2020 · Haijun Huang, Shanshan Chen, et al. · Alimentary Pharmacology & Therapeutics · 36
Transoral versus gasless transaxillary endoscopic thyroidectomy: a comparative study
2021 · Guibin Zheng, Jiajie Xu, et al. · Updates in Surgery · 33
KRAS mutation-driven angiopoietin 2 bestows anti-VEGF resistance in epithelial carcinomas
2023 · Kayoko Hosaka, Patrik Andersson, et al. · Proceedings of the National Academy of Sciences · 27
Prevalence and Characteristics of Hypoxic Hepatitis in COVID-19 Patients in the Intensive Care Unit: A First Retrospective Study
2021 · Haijun Huang, Hong Li, et al. · Frontiers in Medicine · 27
PDF
COVID-19 instigates adipose browning and atrophy through VEGF in small mammals
2022 · Xu Jing, Jieyu Wu, et al. · Nature Metabolism · 26
PDF
Targeting SIGLEC15 as an emerging immunotherapy for anaplastic thyroid cancer
2024 · Lisha Bao, Ying Li, et al. · International Immunopharmacology · 25
A signature of circadian rhythm genes in driving anaplastic thyroid carcinoma malignant progression
2022 · Tong Xu, Tiefeng Jin, et al. · Cellular Signalling · 25
Efficacy and safety of selpercatinib in Chinese patients with advanced RET -altered thyroid cancers: results from the phase II LIBRETTO-321 study
2022 · Xiangqian Zheng, Qinghai Ji, et al. · Therapeutic Advances in Medical Oncology · 21
PDF
Works count: 105
Citation count: 1,637
H-index: 24
I10-index: 36
Year
Topic
Type